Evidence map›Paper›PMID 10828885›Full record

ArticleOncogene2000

CBP/p300 histone acetyl-transferase activity is important for the G1/S transition.

S Ait-Si-Ali, A Polesskaya, S Filleur, R Ferreira, A Duquet, P Robin, A Vervish, D Trouche, F Cabon, A Harel-Bellan

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 140 citations in OpenAlex.

  1. Exploring the Regulation ofJournal of developmental biology · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer.Cold Spring Harbor perspectives in medicine · 2017
    Review
  20. The Temporal Regulation of S Phase Proteins During GAdvances in experimental medicine and biology · 2017
    Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

S Ait-Si-AliLaboratoire 'Oncogenèse, Différenciation et Transduction du Signal' CNRS IFC-01, 7 rue Guy Moquet, 94801 Villejuif, France.
A Polesskaya
S Filleur
R Ferreira
A Duquet
P Robin
A Vervish
D Trouche
F Cabon
A Harel-Bellan
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transforming viral proteins such as E1A which force quiescent cells into S phase have two essential cellular target proteins, Rb and CBP/p300. Rb regulates the G1/S transition by controlling the transcription factor E2F. CBP/p300 is a transcriptional co-activator with intrinsic histone acetyl-transferase activity. This activity is regulated in a cell cycle dependent manner and shows a peak at the G1/S transition, suggesting a function for CBP/p300 in this crucial step of the cell cycle. Here, we have artificially modulated CBP/p300 levels in individual cells through microinjection of specific antibodies and expression vectors. We show that CBP/p300 is required for cell proliferation and has an essential function during the G1/S transition. Using the same microinjection system and GFP-reporter vectors, we demonstrate that CBP/p300 is essential for the activity of E2F, a transcription factor that controls the G1/S transition. In addition, our results suggest that CBP HAT activity is required both for the G1/S transition and for E2F activity. Thus CBP/p300 seems to be a versatile protein involved in opposing cellular processes, which raises the question of how its multiple activities are regulated.

Indexed as

Carrier ProteinsG1 PhaseS Phase3T3 CellsAcetyltransferasesAnimalsCell Cycle ProteinsCOS CellsDNA-Binding ProteinsE2F Transcription FactorsHistone AcetyltransferasesMiceMutagenesisp300-CBP-Associated Factorp300-CBP Transcription FactorsProtein BindingAcetyltransferasesArid4a protein, mouseCarrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsE2F Transcription FactorsHistone Acetyltransferasesp300-CBP-Associated Factorp300-CBP Transcription FactorsRetinoblastoma-Binding Protein 1TATA-Box Binding ProteinTranscription Factor DP1Transcription Factors

Identifiers

PMID10828885
OpenAlexW2312414085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.